According to the research report, the global diabetesdevices market size is expected to touch USD 48.8 Billion by 2030, from USD 30 Billion in 2022, growing with a significant CAGR of 6.2% from 2022 to 2030.
The diabetes devices report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global diabetes devices in conjunction
with the geographical landscape of this vertical have also been included in
this report.
The report offers intricate dynamics about
different aspects of the global diabetes devices market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global diabetes devices during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1321
| Report Coverage | Details |
| Market Size in 2020 | USD 26.7 Billion |
| Growth Rate | CAGR of 6.2% From 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Distribution Channel, End User, Region |
This study covers a detailed segmentation
of the global diabetes devices market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global diabetes devices market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- B Braun Melsungen AG
- Abbott Laboratories
- Bayer AG
- Medtronic Plc
- F.Hoffman-La-Ltd.
- Lifescan, Inc.
- Dexcom, Inc.
- Sanofi
- Tandem Diabetes Care, Inc.
- Companion Medical
Market Segmentation
- Blood Glucose Monitoring
- Self-Monitoring
- Continuous Glucose Monitoring
- Insulin Delivery Devices
- Pens
- Pumps
- Jet Injectors
- Syringes
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Clinics
- Online Pharmacy
- Others
By End Use
- Diagnostic Center
- Hospitals
- Home Care
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global diabetes devices report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global diabetes devices market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diabetes Devices Market, By Type
7.1. Diabetes Devices Market, by Type, 2021-2030
7.1.1. Blood Glucose Monitoring
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Insulin Delivery Devices
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Diabetes Devices Market, By Application
8.1. Diabetes Devices Market, by Application, 2021-2030
8.1.1. Diagnostic Center
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Home Care
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Diabetes Devices Market, By Distribution Channel
9.1. Diabetes Devices Market, by Distribution Channel, 2021-2030
9.1.1. Retail Pharmacy
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Hospital Pharmacy
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Online Pharmacy
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)
Chapter 11. Company Profiles
11.1. B Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bayer AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F.Hoffman-La-Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lifescan, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tandem Diabetes Care, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Companion Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments